Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.

bioRxiv : the preprint server for biology·2026
Same author

EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer.

Research square·2025
Same author

EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer.

bioRxiv : the preprint server for biology·2025
Same author

The Role of Non-Coding RNAs in MYC-Mediated Metabolic Regulation: Feedback Loops and Interactions.

Non-coding RNA·2025
Same author

Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer.

Cancer research·2024
Same author

The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids.

Nature communications·2024

Related Experiment Videos

From Tissue Specificity to Systemic Cues: Shaping MYC‑Driven Tumor Metabolism.

Aliaa Amr Alamoudi1, Yiming Mao2, Giorgia Zadra3

  • 1King Abdulaziz University Jeddah Saudi Arabia.

Cancer Research
|July 14, 2026
PubMed
Summary

The proto-oncogene MYC drives cancer metabolism, but its effects vary by context. Understanding these MYC-driven metabolic changes reveals vulnerabilities for targeted cancer therapies.

Related Experiment Videos

Area of Science:

  • Oncology
  • Metabolic pathways
  • Cancer biology

Background:

  • The proto-oncogene MYC is a key regulator of cellular metabolism.
  • MYC's metabolic targets are context-dependent, influenced by tissue type, mutations, and the tumor microenvironment (TME).
  • Extrinsic factors like diet and systemic metabolism further modulate MYC's impact on cancer metabolism.

Purpose of the Study:

  • To review MYC-driven metabolic alterations in vivo.
  • To explore how tissue specificity, TME interactions, and systemic factors shape MYC's metabolic influence.
  • To identify context-dependent vulnerabilities in MYC-driven cancers for therapeutic development.

Main Methods:

  • Literature review of in vivo studies on MYC and cancer metabolism.
  • Analysis of tissue-specific metabolic programs regulated by MYC.
  • Examination of interactions between MYC, the TME, and systemic metabolic influences.

Main Results:

  • MYC orchestrates diverse metabolic programs crucial for tumor initiation and progression.
  • The specific metabolic pathways activated by MYC are highly dependent on the cellular and organismal context.
  • MYC-driven metabolic reprogramming creates unique vulnerabilities exploitable for cancer treatment.

Conclusions:

  • MYC's role in cancer metabolism is complex and context-specific.
  • Targeting MYC-driven metabolic vulnerabilities offers a promising avenue for precision cancer therapy.
  • Further research into the multifaceted metabolic landscape governed by MYC is essential for advancing treatment strategies.